Jonas Blaes

Ludwigshafen Am Rhein, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn's Disease Studies.

HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn's Disease Studies.

Journal: Journal of Crohn's & colitis

Published: May 28, 2024

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.

Journal: Clinical pharmacokinetics

Published: February 06, 2023

A first-in-human study of the novel immunology antibody-drug conjugate, ABBV-3373, in healthy participants.

A first-in-human study of the novel immunology antibody-drug conjugate, ABBV-3373, in healthy participants.

Journal: British journal of clinical pharmacology

Published: January 24, 2023

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum.

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum.

Journal: Bioanalysis

Published: March 17, 2021

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.

Journal: Molecular cancer research : MCR

Published: October 04, 2017

Tweety-Homolog 1 Drives Brain Colonization of Gliomas.

Tweety-Homolog 1 Drives Brain Colonization of Gliomas.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: November 14, 2016

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 01, 2016

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.

Journal: Oncotarget

Published: May 11, 2016

Prognostic relevance of miRNA-155 methylation in anaplastic glioma.

Prognostic relevance of miRNA-155 methylation in anaplastic glioma.

Journal: Oncotarget

Published: May 09, 2016

NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.

NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.

Journal: Cancer letters

Published: January 06, 2015

Brain tumour cells interconnect to a functional and resistant network.

Brain tumour cells interconnect to a functional and resistant network.

Journal: Nature

Published: December 15, 2014

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.

Journal: Oncotarget

Published: October 26, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026